Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
about
Anticancer mechanisms of cannabinoidsTrauma equals danger--damage control by the immune systemEpigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in OffspringAnandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA inductionHistone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responsesRole of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiolCannabis use by individuals with multiple sclerosis: effects on specific immune parameters.Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.Many mechanisms mediating mobilization: an alliterative review.Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells.Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Endocannabinoid signalling and the deteriorating brainΔ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation.Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation.Adoptive cell transfer in autoimmune hepatitis.Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers.Δ⁹-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood.Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2.Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
P2860
Q26750399-693D5CA0-5A94-4311-88E8-5FF2FC1614B1Q26860731-041CE897-375D-4DB3-BC78-3EE71A27FD42Q26864359-AE2EF1AD-616B-47A5-9002-B43BD4CA6E5BQ31156796-9CD827A6-4983-45E0-8BFF-C864C863FE63Q33846410-2C8F3C33-5814-4B82-83FC-C116DEC72EEBQ33869556-BBEBCB40-6658-4A2B-90A0-32EC33808C73Q34219132-F7829CB3-AEE1-4AEC-938B-62B88EFA52E4Q34339177-F5417127-BD39-41C8-9D5D-9AA344A9783FQ35173866-313A58FA-DC69-4123-921B-88261066839CQ35188151-CEBC7BEC-85B0-4CA1-9B31-2D2A8E5A756CQ35207111-E8B3F8AC-FE78-4A9C-85FE-7F30E0074BF0Q35223945-28FD5A46-5FE2-41DC-8790-3938D163A21FQ35429696-05B77362-ADDB-4F13-8184-9EC1B7A94345Q35613040-D12C8C6C-54BF-4F65-8BDC-F11E7049F368Q35754490-EC0ECBD0-FEA7-478D-85B3-F5B3109A7FCAQ35970488-14DC4184-EE09-4B46-8666-CE7FE1476A65Q36422338-4AE1191E-F167-4C58-A797-C5F4766C6489Q37117257-644DDC2D-3223-4473-8706-12EEAD74DC9FQ37415572-8C90ED16-9E94-467F-8CBC-9D46E43AE050Q37512670-0FBD9E2A-F7C7-4D38-A15E-2483BB5EDEA0Q37644978-1A8137FC-51BB-4ED9-8966-FD3448AFAA60Q37648708-47626FB8-D147-410A-B448-72BC17EEBFE1Q38709451-BA8349C8-9999-442D-B149-63EBB4EF69C7Q39035161-6871CC08-3222-4BF3-8044-2D65306DF39BQ40594444-F6DF317B-A62B-4620-B169-EF181C1229C6Q43785645-67C638EA-3C29-4A52-BE48-DF6FFD1A69DBQ50013540-C150BEA2-826A-41BF-B18D-BB45D63D426FQ52304505-CF827D55-12F9-4559-9D1F-1D7514F73243Q54490551-A3786BD8-D556-46B9-886D-8A61FE2B3710Q58801886-1C02F07B-36D0-42FE-B984-E8778871775E
P2860
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cannabinoid receptor activatio ...... t immunosuppressive properties
@ast
Cannabinoid receptor activatio ...... t immunosuppressive properties
@en
Cannabinoid receptor activatio ...... t immunosuppressive properties
@nl
type
label
Cannabinoid receptor activatio ...... t immunosuppressive properties
@ast
Cannabinoid receptor activatio ...... t immunosuppressive properties
@en
Cannabinoid receptor activatio ...... t immunosuppressive properties
@nl
prefLabel
Cannabinoid receptor activatio ...... t immunosuppressive properties
@ast
Cannabinoid receptor activatio ...... t immunosuppressive properties
@en
Cannabinoid receptor activatio ...... t immunosuppressive properties
@nl
P2860
P921
P356
P1476
Cannabinoid receptor activatio ...... t immunosuppressive properties
@en
P2093
Mitzi Nagarkatti
Prakash S Nagarkatti
P2860
P304
P356
10.1002/EJI.201040667
P407
P577
2010-12-01T00:00:00Z